Telix Pharmaceuticals TLX
NASDAQ TLX
$10.79 -0.18 (-1.64%)
As of: Oct 1, 2026 · 12:41 PM EDT

Telix Pharmaceuticals (TLX) Long-Term Deferred Tax (2023 - 2026)

Updated

Telix Pharmaceuticals' Long-Term Deferred Tax came in at $85.3 million for the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Long-Term Deferred Tax (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Telix Pharmaceuticals' Long-Term Deferred Tax was $59.35 million, up 105.2% from the prior year.

  • Going back by year, Long-Term Deferred Tax was $28.92 million in the year ended Dec 31, 2024 (+106.7%) and $13.99 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Telix Pharmaceuticals 3.72 Bn 2.66 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 85.30 Mn
Dec 31, 2025 59.35 Mn
Dec 31, 2024 30.56 Mn
Dec 31, 2023 13.31 Mn
API Access

Telix Pharmaceuticals Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=TLX&period=max&api_key=YOUR_API_KEY